DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,489,000 | +38.2% | 171,661 | -5.5% | 4.72% | +30.4% |
| Q2 2016 | $1,801,000 | -13.0% | 181,661 | -16.6% | 3.62% | -27.4% |
| Q1 2016 | $2,071,000 | -19.5% | 217,805 | -5.2% | 4.99% | +4.8% |
| Q4 2015 | $2,574,000 | +93.5% | 229,841 | +141.9% | 4.76% | +87.7% |
| Q3 2015 | $1,330,000 | -30.3% | 95,000 | -36.7% | 2.54% | -8.0% |
| Q2 2015 | $1,908,000 | – | 150,000 | – | 2.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 194,340 | $253,000 | 0.02% |
| MIDDLETON & CO INC/MA | 15,848 | $21,000 | 0.01% |
| Acrospire Investment Management LLC | 4,220 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,942 | $26,000 | 0.00% |
| A.R.T. Advisors, LLC | 32,426 | $42,000 | 0.00% |
| FNY Partners Fund LP | 500 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 43,447 | $56,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 13,200 | $17,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,378 | $32,000 | 0.00% |
| MORGAN STANLEY | 7,566 | $10,000 | 0.00% |